Categories AlphaGraphs, Earnings, Health Care
LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report
Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter of 2024. The pharma giant also raised its full-year guidance.
Worldwide revenue increased 36% annually to $11.3 billion in the June quarter, driven mainly by strong sales of Mounjaro, Zepbound, and Verzenio.
Second-quarter reported net income increased 68% from last year to $3.0 billion, or $3.8 per share. Adjusted earnings climbed 86% year-over-year to $3.92 per share.
The management raised its full-year revenue guidance to the range of $45.4 billion to $ 46.6 billion. EPS forecast and adjusted EPS forecast have been raised to $15.10-15.60 and $16.10-16.60, respectively.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Adobe (ADBE) to report Q3 earnings on Sept 12. Here’s what to expect
After delivering record-high revenues in the second quarter, Adobe Inc. (NASDAQ: ADBE) is gearing up to report third-quarter results next week. The design software maker has effectively integrated advanced AI
A look at Campbell Soup’s (CPB) expectations for fiscal year 2025
Shares of Campbell Soup Company (NASDAQ: CPB) rose over 1% on Friday. The stock has gained 21% over the past three months. The company delivered sales and earnings growth for
DOCU Earnings: DocuSign Q2 2025 profit jumps on higher revenues
DocuSign, Inc. (NASDAQ: DOCU) reported a sharp increase in adjusted earnings for the second quarter of 2025. The bottom line benefitted from a 7% increase in revenues. The eSignature service
